Ive lost 35 pounds and Ive got about 35 to go
Weekly dosing also reduces fluctuations in medication levels that can trigger nausea or breakthrough hunger between doses
Amongst T2D patients inadequately controlled by metformin (with or without sulfonylurea), the efficacy and safety of oral semaglutide have been demonstrated across the PIONEER clinical trials program [15, 16], and the efficacy and safety of subcutaneous semaglutide have been demonstrated across the SUSTAIN clinical trials program [17, 18]
User-friendliness and faster simulation times of a cohort model can be valuable for stakeholders evaluating the cost-effectiveness of T2D interventions [20]
Recent findings also revealed concerns with the loss of skeletal muscle mass when taking GLP-1RAs with some studies reporting up to 50% of weight loss being due to decreases in muscle mass
If nausea, constipation, or fatigue are significantly impacting quality of life, holding the current dose or even temporarily reducing can allow the body to adapt before moving forward
.webp)
